April 16, 2026 LEO Pharma Announces FDA Acceptance of Supplemental NDA for ANZUPGO® (delgocitinib) Cream for the Treatment of Chronic Hand Eczema in Children Aged 12-17
April 16, 2026 Arrive AI Announces Fourth Quarter and Full-Year 2025 Results, Highlights Progress Toward Scaling Autonomous Delivery Network